LabCorp Launches NIPT on Illumina System; Agreement with Ariosa Now Non-Exclusive | GenomeWeb

NEW YORK (GenomeWeb) – Laboratory Corporation of America said this week that it has developed and launched a noninvasive prenatal test for fetal chromosomal abnormalities. It will offer the test through Integrated Genetics, part of the LabCorp Specialty Group of labs that offer esoteric and genomic testing.

The test, called InformaSeq Prenatal Test, will screen for multiple fetal chromosomal abnormalities and will have testing options for several common sex-related aneuploidies. The test will run on an as of yet unspecified Illumina platform.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.